Efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial

BACKGROUND: Neutropenia is a common complication from chemotherapy. Mecapegfilgramtim (code name HHPG-19K), a long-acting recombinant human granulocyte colony-stimulating factor (rhG-CSF), has been developed. This study was to evaluate the efficacy and safety of mecapegfilgrastim for reducing neutro...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Transl Med
Hlavní autoři: Xu, Fengrui, Zhang, Yang, Miao, Zhanhui, Zeng, Xiaohua, Wu, Biao, Cai, Li, Liu, Jinping, Wang, Shusen, Hu, Xichun, Zheng, Wenbo, Chen, Zhiyue, Yang, Qing, Jiang, Zefei
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6803220/
https://ncbi.nlm.nih.gov/pubmed/31700918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.07.95
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky